Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Indivior PLC - Ordinary Shares (INDV)
Company Research
Source: Seeking Alpha
Timothy Dyer - Co-Founder, CEO & Director Mikhail Kalinichev - Head of Translational Science Conference Call Participants Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Addex Therapeutics Third Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, Tim Dyer, CEO. Please go ahead. Timothy Dyer Co-Founder, CEO & Director Thank you. Hello, everyone. I'd like to thank you all for attending our third quarter 2025 financial results conference call. I'm here with Misha Kalinichev, our Head of Translational Science, who will be providing an update on our R&D programs. I draw your attention to the press release and the financial statements issued earlier today, which are available on our website.
Show less
Read more
Impact Snapshot
Event Time:
INDV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INDV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INDV alerts
High impacting Indivior PLC - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
INDV
News
- Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice Matter [Yahoo! Finance]Yahoo! Finance
- Indivior Concludes Legacy U.S. Department of Justice MatterPR Newswire
- Indivior to Participate in the Piper Sandler 37th Annual Healthcare ConferencePR Newswire
INDV
Earnings
- 10/30/25 - Beat
INDV
Sec Filings
- 11/20/25 - Form 8-K
- 11/14/25 - Form 8-K
- 11/13/25 - Form SCHEDULE
- INDV's page on the SEC website